1887

Abstract

. BALB/c mice given a live vaccine of an A mutant of by intraperitoneal (i.p.) injection were not protected against i.p. challenge with its virulent parental strain but were protected against i.p. challenge with either of two virulent strains of (O [1],4,[5],12). Vaccination with a live vaccine of A protected against challenge with but not with . Intraperitoneal administration of either strain evoked high levels of serum antibody against the homologous lipopolysacharide (LPS) as determined by an enzyme immunoassay. Sera from vaccinated mice also reacted with heterologous LPS but at dilutions at least seven-fold lower than homologous endpoint titres. The vaccination schedule employed with either live-vaccine strain conferred an equal degree of resistance to challenge with . After mixed infection of mice with equal numbers of virulent and by the i.p. route, the former was isolated in numbers at least 50 000 times greater than the latter from the liver and spleen between days 1 and 5. When mice were vaccinated i.p. with , or before mixed infection, neither serotype showed more than a slight predominance in the liver and spleen during the same period. Thus, in relative terms, vaccination with or inoculation with unrelated bacteria suppressed the growth of virulent in mice but allowed virulent to multiply. These results clearly show that 38 can multiply to kill immunised BALB/c mice.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-31-4-225
1990-04-01
2022-11-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/31/4/medmicro-31-4-225.html?itemId=/content/journal/jmm/10.1099/00222615-31-4-225&mimeType=html&fmt=ahah

References

  1. Abernathy R S. 1957; Homologous and heterologous resistance in mice given bacterial endotoxins. Journal of Bacteriology 78:387–394
    [Google Scholar]
  2. Blanden R V, Mackaness G B, Collins F M. 1966; Mechanisms of acquired resistance in mouse typhoid. Journal of Experimental Medicine 124:585–600
    [Google Scholar]
  3. Carlin N I A, Svenson S B, Lindberg A A. 1987; Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid. Microbial Pathogenicity 2:171–118
    [Google Scholar]
  4. Cluff L E. 1970; Effects of endotoxins on susceptibility to infections. Journal of Infectious Diseases 122:205–215
    [Google Scholar]
  5. Collins F M. 1968; Cross-protection against Salmonella enteritidis infection in mice. Journal of Bacteriology 95:1343–1349
    [Google Scholar]
  6. Collins F M. 1979; Cellular antimicrobial immunity. CRC Critical Reviews in Microbiology 7:27–91
    [Google Scholar]
  7. Colwell D E, Michalek S M, Briles D E, Jirillo E, McGhee J R. 1984; Monoclonal antibodies to salmonella lipopolysacchar-ide: Anti O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium. Journal of Immunology 133:950–957
    [Google Scholar]
  8. Darveau R P, Hancock R E W. 1983; Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. Journal of Bacteriology 155:831–838
    [Google Scholar]
  9. Eisenstein T K, Killar L M, Stocker B A D, Sultzer B M. 1984; Cellular immunity induced by avirulent salmonella in LPS-defective C3H/HeJ mice. Journal of Immunology 133:958–961
    [Google Scholar]
  10. Friedman R L, Moon R J. 1977; Hepatic clearance of Salmonella typhimurium in silica-treated mice. Infection and Immunity 16:1005–1012
    [Google Scholar]
  11. Griffith R W, Kramer T T. 1982; Sensitivity of smooth Salmonella choleraesuis var. Kunzendorf field strains to antibody and complement under various conditions. American Journal of Veterinary Research 43:1413–14140
    [Google Scholar]
  12. Herzberg M, Nash P, Hino S. 1972; Degree of immunity induced by killed vaccines to experimental salmonellosis. Infection and Immunity 5:83–90
    [Google Scholar]
  13. Hochadel J F, Keller K F. 1977; Protective effects of passively transferred immune T or B lymphocytes in mice infected with Salmonella typhimurium. Journal of Infectious Diseases 135:813–823
    [Google Scholar]
  14. Huang C T, Lo C B. 1967; Human infections with Salmonella choleraesuis in Hong Kong. Journal of Hygiene 65:149–163
    [Google Scholar]
  15. Kuusi N, Nurminen M, Saxen H, Valtonen M, Makela P H. 1979; Immunization with major outer membrane proteins in experimental salmonellosis of mice. Infection and Immunity 25:857–862
    [Google Scholar]
  16. Levine M M, Hornick R B. 1981; Immunology of enteric pathogens: Salmonella, Shigella and Escherichia coli. In:. Nahmias A J, O'Reilly R J. Immunology of human infection Part I: Bacteria, mycoplasmae, chlamydias and fungi. (Comprehensive Immunology 8) Plenum; New York:249–290
    [Google Scholar]
  17. Liang–Takasaki C J, Grossman N, Leive L. 1983; Salmonellae activate complement differentially via the alternate pathway depending on the structure of their lipopolysaccharide O-antigen. Journal of Immunology 130:1867–18730
    [Google Scholar]
  18. Liang–Takasaki C J, Makela P H, Leive L. 1982; Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters the interaction with complement and macrophages. Journal of Immunology 128:1229–12320
    [Google Scholar]
  19. Lindberg A A, Rosenberg L T, Ljunggren A, Garegg P J, Svensson S, Wallin N–H. 1974; Effect of synthetic disacchar-ide protein conjugate as an immunogen in salmonella infection in mice. Infection and Immunity 10:541–545
    [Google Scholar]
  20. Lyman M B, Stocker B A D, Roantree R J. 1979; Evaluation of the immune response directed against salmonella antigenic factors O4,5 and O9. Infection and Immunity 26:956–965
    [Google Scholar]
  21. MacCready R A, Reardon J P, Saphra I. 1957; Salmonellosis in Massachusets: a sixteen-year experience. New England Journal of Medicine 256:1121–1128
    [Google Scholar]
  22. Mackaness G B. 1964; The immunological basis of acquired cellular resistance. Journal of Experimental Medicine 120:105–120
    [Google Scholar]
  23. McCabe W R. 1972; Immunisation with R mutants of 5. minnesota. I. Protection against challenge with heterologous gram negative bacilli. Journal of Immunology 08:601–610
    [Google Scholar]
  24. McCabe W R, Johns M A, Craven D E, Bruins S C. 1977; Clinical implications of enterobacterial antigens. In: Schles-singer D (ed) Microbiology. American Society for Microbiology Washington DC:293–297
    [Google Scholar]
  25. Moon R J, Vrable R A, Broka J A. 1975; In–situ separation of bacterial trapping and killing functions of the perfused liver. Infection and Immunity 12:411–418
    [Google Scholar]
  26. Morrison D C, Ulevitch R J. 1978; The effect of bacterial endotoxins on host mediation systems. American Journal of Pathology 93:526–617
    [Google Scholar]
  27. Nnalue N A, Stocker B A D. 1986; Some galE mutants of Salmonella choleraesuis retain virulence. Infection and Immunity 54:635–640
    [Google Scholar]
  28. Nnalue N A, Stocker B A D. 1987; Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis. Infection and Immunity 55:955–962
    [Google Scholar]
  29. Nnalue N A, Stocker B A D. 1987b; The effects of O-antigen character and enterobacterial common antigen content on the in-vivo persistence of aromatic-dependent Salmonella sp. live-vaccine strains. Microbial Pathogenesis 3:31–44
    [Google Scholar]
  30. Ornellas E P, Roantree R J, Steward J P. 1970; The specificity and importance of humoral antibody in the protection of mice against intraperitoneal challenge with complement-sensitive and complement-resistant salmonella. Journal of Infectious Diseases 121:113–123
    [Google Scholar]
  31. Ornellas E P, Stocker B A D. 1974; Relation of lipopolysaccharide character to PI sensitivity. Salmonella typhimurium. Virology 60:491–502
    [Google Scholar]
  32. Saphra I, Winter J W. 1957; Clinical manifestations of salmonellosis in man: an evaluation of 7779 human infections identified at the New York Salmonella center. New England Journal of Medicine 256:1128–11350
    [Google Scholar]
  33. Saxen H, Reima I, Makela P H. 1987; Alternative complement pathway activation by salmonella O polysaccharide as a virulent determinant in the mouse. Microbial Pathogenesis 2:15–28
    [Google Scholar]
  34. Schlecht S. 1981; Active immunization to experimental salmonellosis in mice. Protective properties of salmonella R mutants against infection with different pathogenic Salmonella species. Zentralblatt fur Bakteriology and Hygiene I Abt. Orig. A 249:362–372
    [Google Scholar]
  35. Smith B P et al. 1984; Aromatic–dependent Salmonella typhimurium as modified live-vaccines for calves. American Journal of Veterinary Research 45:59–66
    [Google Scholar]
  36. Smith H W, Halls S. 1966; The immunity produced by a rough Salmonella dublin variant against Salmonella typhimurium and Salmonella choleraesuis infection in guinea pigs. Journal of Hygiene 64:357–359
    [Google Scholar]
  37. Smith H W. 1965; The immunization of mice, calves and pigs against Salmonella dublin and Salmonella choleraesuis infections. Journal of Hygiene 63:117–135
    [Google Scholar]
  38. Svenson S B, Nurminen M, Lindberg A A. 1979; Artificial salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infection and Immunity 25:863–872
    [Google Scholar]
  39. Valtonen M V. 1977; Role of phagocytosis in mouse virulence of Salmonella typhimurium recombinants with O-antigen 6,7 or 4,12. Infection and Immunity 18:574–82
    [Google Scholar]
  40. Valtonen M V, Plosila M, Valtonen V V, Makela P H. 1975; Effect of the quality of the lipopolysaccharide on mouse virulence of Salmonella enteritidis. Infection and Immunity 12:828–832
    [Google Scholar]
  41. Vuopio–Varkila J, Nurminen M, Phyala L, Makela P H. 1988; Lipopolysaccharide-induced non-specific resistance to systemic Escherichia coli infection in mice. Journal of Medical Microbiology 25:197–203
    [Google Scholar]
  42. Weissbluth M, Shulman S T, Holson B, Lerner C. 1981; Salmonella cholerae-suis: a distinctive bacterial pathogen. Journal of Pediatrics 98:423–426
    [Google Scholar]
  43. Wong J C S, Kucera C J. 1982; Cross–protection by a chemically altered vaccinal strain of Pasteurella multocida in mice and hamsters. American Journal of Veterinary Research 43:1315–1316
    [Google Scholar]
  44. Zinkernagel R M. 1976; Cell–mediated immune response to Salmonella typhimurium infection in mice: development of nonspecific bactericidal activity against Listeria monocytogenes. Infection and Immunity 13:1069–10710
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-31-4-225
Loading
/content/journal/jmm/10.1099/00222615-31-4-225
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error